Status:
RECRUITING
NAC vs Placebo on Opioid Use for Hysterectomy
Lead Sponsor:
Medical University of South Carolina
Conditions:
Hysterectomy
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
This study will enroll females who are ages 18 and older undergoing a laparoscopic or robotic, partial or full hysterectomy. Participants will be randomized to receive IV n-acetylcysteine or placebo d...
Eligibility Criteria
Inclusion
- Inclusion
- Undergoing elective laparoscopic or robotic, full, or partial hysterectomy procedure
- 18 years of age and older
- Exclusion
- Less than 40kg in weight
- Unable to provide written, informed consent
- History of an adverse or anaphylactoid reaction to acetylcysteine
- Active asthma, wheezing, or using inhaled bronchodilators
- Non-English speaking
- Insulin dependent diabetes if D5W is required
- Blood clotting disorders
Exclusion
Key Trial Info
Start Date :
November 30 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 9 2026
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT06039566
Start Date
November 30 2023
End Date
December 9 2026
Last Update
October 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of South Carolina
Charleston, South Carolina, United States, 29425